Phase I/II multicenter clinical trial of lenalidomide maintenance after allogeneic hematopoietic cell transplant (alloHCT) in patients with high risk (HR) multiple myeloma (MM) Meeting Abstract


Authors: Becker, P. S.; Alsina, M.; Zhong, X. B.; Hari, P. N.; Rowley, S.; Stadtmauer, E. A.; Vesole, D.; Logan, B. R.; Weisdorf, D. J.; Qazilbash, M.; Popplewell, L.; Navarro, W. H.; Tomblyn, M.; Giralt, S. A.; Pasquini, M. C.
Abstract Title: Phase I/II multicenter clinical trial of lenalidomide maintenance after allogeneic hematopoietic cell transplant (alloHCT) in patients with high risk (HR) multiple myeloma (MM)
Meeting Title: 2013 BMT Tandem Meetings
Journal Title: Biology of Blood and Marrow Transplantation
Volume: 19
Issue: 2 Suppl. 2
Meeting Dates: 2013 Feb 13-17
Meeting Location: Salt Lake City, UT
ISSN: 1083-8791
Publisher: Elsevier Inc.  
Date Published: 2013-02-01
Start Page: S154
Language: English
ACCESSION: WOS:000314441900081
PROVIDER: wos
DOI: 10.1016/j.bbmt.2012.11.111
Notes: - Oral Presentations Meeting Abstract: 80 - BMT Tandem Meetings - FEB 13-17, 2013 - Salt Lake City, UT - "2" - "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Sergio Andres Giralt
    1051 Giralt